Space diversity receiving system
    4.
    发明授权
    Space diversity receiving system 失效
    空间分集接收系统

    公开(公告)号:US4864642A

    公开(公告)日:1989-09-05

    申请号:US176527

    申请日:1988-04-01

    IPC分类号: H04B7/08

    CPC分类号: H04B7/0814 H04B7/0831

    摘要: A space diversity system capable of operating accurately over a wide range of received input electric field strengths. With a middle or high received electric field strength, a search operation for the antenna with the highest strength is commenced in response to noise detected in the output of the antenna presently selected. With a low received electric field strength, the search operation is carried out in response to noise such as white noise at all times.

    Headrest and vehicle seat provided with the same
    5.
    发明授权
    Headrest and vehicle seat provided with the same 有权
    头枕和车辆座椅配有相同的

    公开(公告)号:US08936310B2

    公开(公告)日:2015-01-20

    申请号:US13371940

    申请日:2012-02-13

    IPC分类号: B60N2/42 B60N2/48 B60N2/427

    摘要: A headrest including: a headrest body that supports a head portion of an occupant; a pair of side frame sections that supports the headrest body, the side frame sections extending along a seat height direction and disposed at a separation from each other along a seat width direction; and an inclined wall portion that is provided between the side frame sections, that is inclined towards a seat front-rear direction front side with respect to the side frame sections such that a lower end portion of the inclined wall portion is positioned further to the seat front-rear direction front side than an upper end portion of the inclined wall portion, and that bears load acting on the headrest body from a seat front-rear direction rear side.

    摘要翻译: 头枕包括:头枕主体,其支撑乘员的头部; 一对侧框架部分,其支撑所述头枕本体,所述侧框架部分沿着座椅高度方向延伸并沿着座椅宽度方向彼此分离设置; 以及设置在所述侧框架部之间的倾斜壁部,所述倾斜壁部相对于所述侧框架部朝向座椅前后方向前侧倾斜,使得所述倾斜壁部的下端部位于所述座部 前后方向前倾侧壁部的上端部,并且从座椅前后方向后侧承受作用在头枕主体上的负荷。

    VEHICLE SEAT
    6.
    发明申请
    VEHICLE SEAT 有权
    车辆座椅

    公开(公告)号:US20140132048A1

    公开(公告)日:2014-05-15

    申请号:US14128488

    申请日:2012-06-13

    IPC分类号: B60N2/42

    摘要: In a seat device, a stay including grommets is set with bending rigidity towards the vehicle front lower than the bending rigidity towards the vehicle rear. Moreover, there is a large displacement of the headrest towards the vehicle front since the stay including the grommets has a lower bending rigidity towards the vehicle front than the bending rigidity towards the vehicle rear. The headrest can be promptly displaced towards the side of the head of the occupant due to setting the bending rigidity of the stay including the grommets, thereby enabling the time until the headrest contacts the head of the occupant to be shortened with a simple configuration.

    摘要翻译: 在座椅装置中,包括索环的支架设置成朝向车辆前方的弯曲刚性低于朝向车辆后部的弯曲刚度。 此外,由于包括索环的保持具有朝向车辆后方的弯曲刚性朝向车辆前方的较低的弯曲刚性,所以头枕朝向车辆前方具有大的位移。 由于设置包括索环的支架的弯曲刚性,头枕可以迅速地朝向乘员的头部移位,从而能够以简单的构造缩短头枕接触乘员头部的时间。

    Thiazolidine compounds and pharmaceutical compositions exhibiting thrombopoietin receptor agonism
    7.
    发明授权
    Thiazolidine compounds and pharmaceutical compositions exhibiting thrombopoietin receptor agonism 失效
    噻唑烷化合物和显示血小板生成素受体激动作用的药物组合物

    公开(公告)号:US07026334B1

    公开(公告)日:2006-04-11

    申请号:US10048008

    申请日:2000-07-24

    IPC分类号: A61K31/427 C07D417/12

    摘要: Pharmaceutical compositions containing as an active ingredient compounds of the general formula (I), prodrugs of the same, pharmaceutically acceptable salts of both, or solvates of them and exhibiting thrombopoietin receptor agonism: wherein X1 is optionally substituted heteroaryl or the like; Y1 is —NRACO— (CH2)0-2— or the like (wherein RA is a hydrogen or the like); Z1 is optionally substituted arylene or the like; and A1 is a ring represented by general formula (II) or (III):

    摘要翻译: 含有作为活性成分的通式(I)化合物,其前体药物,它们的药学上可接受的盐或它们的溶剂合物并且表现出血小板生成素受体激动剂的药物组合物:其中X 1是任选取代的 杂芳基等; Y 1是-NR A - (CH 2)2 - 或其类似物(其中R A是氢等等); Z 1是任选取代的亚芳基等; 和A 1是由通式(II)或(III)表示的环:

    Quinazoline derivatives having tyrosine kinase inhibitory activity
    8.
    发明授权
    Quinazoline derivatives having tyrosine kinase inhibitory activity 有权
    具有酪氨酸激酶抑制活性的喹唑啉衍生物

    公开(公告)号:US08349857B2

    公开(公告)日:2013-01-08

    申请号:US13359326

    申请日:2012-01-26

    摘要: A compound which inhibits both of EGF receptor tyrosine kinase and HER2 tyrosine kinase is provided.A compound represented by the general formula (I): wherein RX is a group represented by the formula: wherein R1 is a hydrogen atom, optionally substituted alkyl, etc.; Z is —O—, —N(R10)—, etc.; R10 is a hydrogen atom, alkyl, etc.; R2 is a hydrogen atom, optionally substituted alkyl, etc.; R18 is a hydrogen atom, optionally substituted alkyl, etc.; R19 is optionally substituted alkyl, etc.; W1 is an optionally substituted non-aromatic nitrogen-containing group; R17 is a hydrogen atom, optionally substituted alkyl, etc.; R3 and R4 are independently a hydrogen atom, optionally substituted alkyl, etc.; X is —O—, —S—, or —N(R12)—, etc.; R12 is a hydrogen atom, alkyl, etc.; and A is phenyl optionally having a substituent, etc., its pharmaceutically acceptable salt, or a solvate thereof.

    摘要翻译: 提供抑制EGF受体酪氨酸激酶和HER2酪氨酸激酶两者的化合物。 由通式(I)表示的化合物:其中RX是由下式表示的基团:其中R1是氢原子,任选取代的烷基等; Z是-O - , - N(R 10) - 等; R10是氢原子,烷基等; R2是氢原子,任选取代的烷基等; R18是氢原子,任意取代的烷基等; R19是任选取代的烷基等; W1是任选取代的非芳族含氮基团; R 17是氢原子,任选取代的烷基等; R3和R4独立地是氢原子,任选取代的烷基等; X是-O-,-S-或-N(R 12) - 等; R12是氢原子,烷基等; 和A是任选具有取代基的苯基等,其药学上可接受的盐或其溶剂合物。

    PHARMACEUTICAL COMPOSITION CONTAINING OPTICALLY ACTIVE COMPOUND HAVING THROMBOPOIETIN RECEPTOR AGONIST ACTIVITY, AND INTERMEDIATE THEREFOR
    9.
    发明申请
    PHARMACEUTICAL COMPOSITION CONTAINING OPTICALLY ACTIVE COMPOUND HAVING THROMBOPOIETIN RECEPTOR AGONIST ACTIVITY, AND INTERMEDIATE THEREFOR 有权
    包含具有血栓素受体激动剂的光学活性化合物的药物组合物及其中间体

    公开(公告)号:US20100267783A1

    公开(公告)日:2010-10-21

    申请号:US12671476

    申请日:2008-07-29

    摘要: An optically active 4-phenylthiazole derivative having a thrombopoietin receptor agonist activity and a pharmaceutical composition containing the present compound as an active ingredient are created, and a platelet production regulating agent which can be orally administered is provided.Disclosed is a pharmaceutical composition containing, as an active ingredient, an optically active compound represented by the formula: wherein, R1 is a halogen atom or C1-C3 alkyloxy; R2 is C1-C8 alkyl; R3 is C1-C8 alkyl; R4 and R5 are each independently a fluorine atom or chlorine atom; R6 is C1-C3 alkyl or C1-C3 alkyloxy; * indicates that a carbon atom marked with an asterisk is an asymmetric carbon, a pharmaceutically acceptable salt thereof, or a solvate thereof.

    摘要翻译: 制备具有血小板生成素受体激动剂活性的光学活性4-苯基噻唑衍生物和含有本发明化合物作为有效成分的药物组合物,提供可口服给药的血小板产生调节剂。 公开了含有下式表示的光学活性化合物作为活性成分的药物组合物:其中,R1为卤素原子或C1-C3烷氧基; R2是C1-C8烷基; R3是C1-C8烷基; R4和R5各自独立地为氟原子或氯原子; R6是C1-C3烷基或C1-C3烷氧基; *表示具有星号的碳原子是不对称碳,其药学上可接受的盐或其溶剂化物。